Michael I. Nishimura

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

C. Marcela Díaz‐Montero, Mohamed L. Salem, Michael I. Nishimura et al. · Cancer Immunology Immunotherapy · 2008 · 1.2K citations

Medicine, Cancer Biology, Oncology +17

Efficient Transfer of a Tumor Antigen-Reactive TCR to Human Peripheral Blood Lymphocytes Confers Anti-Tumor Reactivity

Timothy M. Clay, Mary Custer, Jessica Sachs et al. · The Journal of Immunology · 1999 · 407 citations · Full text

Life Sciences, Immunology, Oncology +17

Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma

Mark E. Dudley, John R. Wunderlich, Michael I. Nishimura et al. · Journal of Immunotherapy · 2001 · 357 citations

Medicine, Immunology, Oncology +17

Recognition of Host Immune Activation by <i>Pseudomonas aeruginosa</i>

Licheng Wu, Oscar Estrada, Olga Zaborina et al. · Science · 2005 · 322 citations

Life Sciences, Immunology, Microbiology +17

Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity

Rachel H. McMahan, Lucy Golden‐Mason, Michael I. Nishimura et al. · Journal of Clinical Investigation · 2010 · 302 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14